Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Actusnews Wire
626 Leser
Artikel bewerten:
(2)

SHOWROOMPRIVE: STRENGTHENING OF DAVID DAYAN'S SHAREHOLDING IN SRP GROUPE AS PART OF THE COMPLETION OF THE SALE OF THIERRY PETIT'S SHARES

Finanznachrichten News

La Plaine Saint Denis, September 1, 2022 - Showroomprivé (SRP Group), a European group specializing in smart shopping, announces that it has been informed of the completion, on August 31 2022, of the acquisition by David Dayan[1] of the remaining 13,932,963 SRP Groupe shares held by Thierry Petit (directly and through TP Invest).

This acquisition was carried out through an off-market transaction at a price of one (1) euro per share, financed by a loan taken out by Ancelle for an amount of €10 million and, for the balance, carried out via an exchange of shares in an unlisted company in which TP Invest and Ancelle both hold a stake.

This acquisition has been the subject of a decision by the Autorité des marchés financiers to waive the requirement to file a public offer, published on August 1 2022. In accordance with the agreements announced on June 21 2022, this acquisition is the final stage in the sale of SRP Groupe shares by Thierry Petit, following the share buyback of 4 million shares by SRP Groupe from TP Invest at the price of one (1) euro per share and the acquisition by Erik Sitruk at the same price of 3 million shares of SRP Groupe from TP Invest.

Following these transactions, and as indicated in the Company's press release of July 29 2022, the Company's shareholding structure will be as follows[2]:

ShareholdersNumber of ordinary shares% of share capitalTheoretical number of voting rights% of voting rights
Founders
Ancelle Sàrl(1)44,195,66837.17%73,283,37347.81%
Victoire Investissement Holding Sàrl(2)2,335,4601,96%4,670,9203.05%
Cambon Financière Sàrl(3)2,079,9301,75%4,159,8602.71%
Thierry Petit(4)----
Total Founders Sub-Concert(5)
.......................................................................
48,611,05840.88%82,114,15353.57%
CRFP 20(6).....................................................10,386,2558.74%10,386,2556.78%
Total Concert with CRF(7)...........................58,997,31349.62%92,500,40860.35%
Eric Sitruk(8)8,955,0007.53%8,955,0005.84%
Other shareholders(9).....................................50,950,59642,85%51,821,49733.81%
TOTAL..........................................................118,902,909100%153,276,905100%
  1. Company controlled by Mr. David Dayan.
  2. Company controlled by Mr. Eric Dayan.
  3. Company controlled by Michaël Dayan.
  4. Includes shares held directly by Thierry Petit and by TP Invest Holding Sàrl, which he controls.
  5. Concert agreement dated October 29 2015 (as amended) concluded in the context of the Company's IPO.
  6. Company controlled by Carrefour Nederland B.V., itself controlled by Carrefour.
  7. Concert agreement dated January 10 2018.
  8. Directly and through the entities Pierre Rénovation Tradition and Financière du Sud.
  9. Including SRP Groupe (4,000,000 shares to be transferred to beneficiaries of free shares).

UPCOMING INFORMATION
Q3 2022 revenue: October 20, 2022

FORWARD-LOOKING STATEMENTS
This press release contains only summary information and is not intended to be comprehensive.
This press release may contain forward-looking information and statements about the Group and its subsidiaries. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Forward-looking statements may be identified by the words "believe," "expect," "anticipate," "goal" or similar expressions. Although the Group appreciates that the expectations reflected in such forward-looking statements are reasonable, investors and the Group's shareholders are cautioned that forward-looking information and statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Group, which could cause actual results and developments to differ materially and adversely from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in filings with the Autorité des Marchés Financiers (France's financial markets authority) made or to be made by the Group (particularly those detailed in Chapter 4 of the Company's registration document). The Group makes no commitment to publicly update its forward-looking statements, whether as a result of new information, future events or otherwise.

ABOUT SHOWROOMPRIVE
Showroomprivé is an innovative European player in the online private sales industry, specialized in fashion. Showroomprivé offers a daily selection of more than 3000 brand partners via its mobile apps or website in France and six other countries. Since its launch in 2006, the company has enjoyed quick growth.

Showroomprivé is listed on Euronext Paris (code: SRP) and reported gross revenue of almost €1 billion incl. VAT[3] in 2021, and net revenue of €724 million. The Group is headed by David Dayan, the co-founder, and employs over 950 people.

For more information: https://showroomprivegroup.com

CONTACTS

Investor RelationsCommunication
Sylvie Chan Diaz, Investor Relations
investor.relations@showroomprive.net
Anne Charlotte Neau-Juillard, Communication
anne-charlotte.neau-juillard@showroomprive.net

Taddeo
presse.showroomprive@taddeo.fr
+33 1 83 97 41 48

[1] Through Ancelle S.à r.l., which it controls.

[2] Based on the total number of shares and voting rights as at June 30 2022, adjusted for the destruction of double voting rights held by the sellers and the acquisition of double voting rights by Ancelle.

[3] Gross Merchandise Volume (GMV) is the total amount transactions invoiced, including all taxes. It therefore includes gross online sales, including sales on the Marketplace, other services and other income

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: m2meYMhmaprGnmuaasiYZ2NnbG1nxmXGamaYmZVta8nJnJ1ilGhnaMfLZnBnlWto
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-76062-press-release-cession-tp-01.09.22.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2022 Actusnews Wire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.